Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
55 Leser
Artikel bewerten:
(0)

Innovation in Laser Fibers: Dornier MedTech HeatFlex' Powering Highest Sterilization & System Performance

MUNICH, March 11, 2016 /PRNewswire/ --Dornier MedTech is a global medical device company known for its pioneering technologies and revolutionary therapies in urology.Dornier will be showcasing their newest holmium laser fiber, Dornier HeatFlex', at the 2016 European Association of Urology's Annual Conference (EAU) in Munich, Germany.

As the name suggests, this fiber is enhanced with special heat-resistance technology enabling it to withstand the extreme temperatures and conditions associated with anti-prion sterilization processes. In addition, given its durable construction, the HeatFlex' fiber also features a unique optical and mechanical connection capability when utilizing Dornier's Medilas H Solvo and UroPulse Laser Systems.These paired features make HeatFlex' one of the most versatile and state-of-the-art fibers on the market today.

"Working efficiently, while preventing the transmission of diseases through medical equipment, is critical.The combined heat-resistant and optimized-connection capability of this new fiber makes HeatFlex an ideal product for urologists looking for the highest levels of performance during kidney stone treatments," said Mary Butler, Chief Technology Officer and VP of Product Marketing for Dornier MedTech.

The fight against transmissible diseases, nosocomial infections, and prion disease is one the highest public health priorities today. Steam sterilization at a temperature of 134C for 18 minutes has been recommended by International health Authorities to provide better assurance of preventing prion disease. HeatFlex' fibers are designed to tolerate these levels without compromising kidney stone treatment performance. HeatFlex also represents the latest in a wave of market innovations Dornier MedTech has been making as part of their commitment to leading technology and improving life.

"One size does not fit all!" said Dr. Alexander Sperl, Physicist and Researcher at Dornier MedTech. "The use of inferior products that do not have this level of heat resistance can open a window for infection and therefore compromising overall kidney stone treatment efforts."

For additional information about Dornier MedTech's HeatFlex' fibers, please contact Valerie Schopmann at +1.770.514.6160 for an interview.Dornier MedTech is showcasing HeatFlex at the European Association of Urology's Annual Conference (EAU) March 11th through the 14th and will have team members on-hand for interviews upon request.

About Dornier MedTech - Dornier MedTech is a wholly-owned subsidiary of Accuron Medical Technology group (www.accuron.com) is a medical device company focused on providing leading technology and improving life by delivering scientifically superior products and solutions to physicians and patients involved in urological care.As pioneers of the lithotripsy and a variety of surgical lasers, Dornier's 40 years of innovation and service has made it one of the most trusted MedTech companies in the industry. Dornier MedTech is headquartered in Munich, Germany with offices and distributors all over the world. For more information, visit www.dornier.com.

About the Accuron Medical Technology Group - The Accuron Medical Technology Group is a privately owned by Temasek Holdings, through the business of Dornier MedTech GmbH, Veredus Laboratories and Advanced Materials Technologies Pte Ltd, provide therapeutic, diagnostic, and medical device manufacturing solutions to customers around the globe.Veredus Laboratories Pte Ltd, specializes in the development, manufacture, and marketing of innovative molecular diagnostic solutions in the clinical, specialty, and custom testing markets based on a proprietary Lab-on-Chip platform.Advanced Materials Technologies Pte Ltd serves the contract manufacturing needs of the medical technology sector through providing materials expertise and high precision engineering capabilities.

© 2016 PR Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.